1. Home
  2. NAMS vs JJSF Comparison

NAMS vs JJSF Comparison

Compare NAMS & JJSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • JJSF
  • Stock Information
  • Founded
  • NAMS 2019
  • JJSF 1971
  • Country
  • NAMS Netherlands
  • JJSF United States
  • Employees
  • NAMS N/A
  • JJSF N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • JJSF Specialty Foods
  • Sector
  • NAMS Health Care
  • JJSF Consumer Staples
  • Exchange
  • NAMS Nasdaq
  • JJSF Nasdaq
  • Market Cap
  • NAMS 2.7B
  • JJSF 2.8B
  • IPO Year
  • NAMS N/A
  • JJSF N/A
  • Fundamental
  • Price
  • NAMS $23.33
  • JJSF $141.53
  • Analyst Decision
  • NAMS Strong Buy
  • JJSF Strong Buy
  • Analyst Count
  • NAMS 7
  • JJSF 1
  • Target Price
  • NAMS $38.17
  • JJSF $200.00
  • AVG Volume (30 Days)
  • NAMS 538.3K
  • JJSF 93.2K
  • Earning Date
  • NAMS 02-06-2025
  • JJSF 02-03-2025
  • Dividend Yield
  • NAMS N/A
  • JJSF 2.13%
  • EPS Growth
  • NAMS N/A
  • JJSF 9.07
  • EPS
  • NAMS N/A
  • JJSF 4.45
  • Revenue
  • NAMS $33,594,000.00
  • JJSF $1,574,755,000.00
  • Revenue This Year
  • NAMS $131.53
  • JJSF $5.79
  • Revenue Next Year
  • NAMS N/A
  • JJSF $3.60
  • P/E Ratio
  • NAMS N/A
  • JJSF $32.01
  • Revenue Growth
  • NAMS 78.77
  • JJSF 1.02
  • 52 Week Low
  • NAMS $15.19
  • JJSF $133.23
  • 52 Week High
  • NAMS $27.29
  • JJSF $180.80
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 44.28
  • JJSF 27.48
  • Support Level
  • NAMS $23.17
  • JJSF $142.07
  • Resistance Level
  • NAMS $26.71
  • JJSF $146.67
  • Average True Range (ATR)
  • NAMS 0.94
  • JJSF 3.97
  • MACD
  • NAMS -0.40
  • JJSF -0.11
  • Stochastic Oscillator
  • NAMS 23.65
  • JJSF 10.18

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About JJSF J & J Snack Foods Corp.

J&J Snack Foods Corp manufactures, markets, and distributes snack foods and beverages to foodservice and retail supermarket outlets. The company's products include frozen beverages, juice, fruit bars, sorbet, cakes, and cookies that are distributed to various consumers, including restaurants, supermarkets, convenience stores, universities, theaters, and theme parks. The company operates in three business segments: food service, which sells snacks, desserts, and baked goods at the point-of-sale; retail supermarkets, which sells frozen and prepackaged products to supermarkets; and frozen beverages, which sells frozen beverages under brands Icee, Slush puppie, and Parrot ice in the United States, Mexico, and Canada.

Share on Social Networks: